Chartwell Investment Partners’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-100,171
Closed -$1.86M 410
2019
Q2
$1.86M Buy
100,171
+1,129
+1% +$21K 0.06% 330
2019
Q1
$2.42M Buy
99,042
+49,160
+99% +$1.2M 0.08% 305
2018
Q4
$1.29M Sell
49,882
-40,167
-45% -$1.04M 0.05% 386
2018
Q3
$2.85M Buy
90,049
+29,812
+49% +$944K 0.08% 319
2018
Q2
$2.34M Sell
60,237
-6,718
-10% -$261K 0.07% 340
2018
Q1
$1.85M Sell
66,955
-135,022
-67% -$3.73M 0.06% 303
2017
Q4
$3.66M Buy
201,977
+57,030
+39% +$1.03M 0.12% 252
2017
Q3
$2.34M Buy
+144,947
New +$2.34M 0.08% 306